{"id":"W2902271181","doi":"10.1056/nejmoa1800474","title":"Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":524,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Health Services and Delivery Research Programme; National Institute of Allergy and Infectious Diseases; Medical Research Council; National Key Research and Development Program of China; National University of Singapore; Seventh Framework Programme; British Columbia Centre for Disease Control; Chinese Center for Disease Control and Prevention; National Institutes of Health; Ministerio de Economía y Competitividad; Bill and Melinda Gates Foundation; European Commission; Wellcome Trust; Wellcome; National Institute for Health and Care Research","keywords":"Ethambutol; Pyrazinamide; Isoniazid; Tuberculosis; Drug resistance; Mycobacterium tuberculosis; Rifampicin; Biology; Genetics; Medicine; Antibiotics; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04542370411130422,"score_gpt":0.3268089577280843,"score_spread":0.2813852536167801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}